New α-methylene-γ-butyrolactones with antimycobacterial properties

Bioorganic and Medicinal Chemistry Letters

Volumn 15, Issue 17, 2005, Pages 3857-3859

  Hughes, Minerva A ^a   McFadden, Jill M ^a   Townsend, Craig A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Butyrolactones; Mycobacteria

Indexed keywords

ALLYLAMINE DERIVATIVE; ANTIMYCOBACTERIAL AGENT; GAMMA BUTYROLACTONE DERIVATIVE; NATURAL PRODUCT;

ARTICLE; DRUG ACTIVITY; DRUG SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION;

4-BUTYROLACTONE; ANTI-BACTERIAL AGENTS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM BOVIS; STRUCTURE-ACTIVITY RELATIONSHIP;

CORYNEBACTERINEAE;

EID: 23244463323     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2005.05.119     Document Type: Article

References (22)

1. H.M.R. Hoffmann, and J. Rabe Angew. Chem. Int. Ed. 24 1985 94
2. Y. Higuch, F. Shimoma, and M. Ando J. Nat. Prod. 66 2003 810
3. K.H. Lee, I.H. Hall, E.C. Mar, C.O. Starnes, S.A. Elgebaly, T.G. Waddell, R.I. Hadgraft, C.G. Ruffner, and I. Weidner Science 196 1977 533
4. K. Ingolfsdottir, G.A.C. Chung, V.G. Skulason, S.R. Gissurarson, and M. Vilhelmsdottir Eur. J. Pharm. Sci. 6 1998 141
5. A.O. Turk, M. Yilmaz, M. Kivanc, and H. Turk Z. Naturforsch C. 58 2003 850
6. E.L. Corbett, C.J. Watt, N. Walker, D. Maher, B.G. Williams, M.C. Raviglione, and C. Dye Arch. Int. Med. 163 2003 1009
7. M.A. Espinal Tuberculosis 83 2003 44 51
8. F.P. Kuhajda, E.S. Pizer, J.N. Li, N.S. Mani, G.L. Frehywot, and C.A. Townsend Proc. Natl. Acad. Sci. USA 97 2000 3450
9. Rendina, A. R.; Cheng, D.; Biochem. J. [online] 2005, doi:10.1042/BJ20041963.
10. F.P. Kuhajda Nutrition 16 2000 202
11. P.J. Brennan Ann. Rev. Biochem. 64 1995 29
12. R.A. Slayden, R.E. Lee, J.W. Armour, A.M. Cooper, I.M. Orme, P.J. Brennan, and G.S. Besra Antimicrob. Agents Chemother. 40 1996 2813
13. N.M. Parrish, F.P. Kuhajda, H.S. Heine, W.R. Bishai, and J.D. Dick J. Antimicrob. Chemother. 43 1999 219
14. H. Marrakchi, G. Laneelle, and A. Quemard Microbiology 146 2000 289
15. O. Zimhony, J.S. Cox, J.T. Welch, C. Vilcheze, and W. Jacobs Nat. Med. 6 2000 1043
16. 3: C, 69.5; H, 9.28. Found: C, 69.5; H, 9.09.
17. T. Kunieda, T. Nagamatsu, T. Higuchi, and M. Hirobe Tetrahedron Lett. 29 1988 2203
18. S. Siddiqi Clinnical Microbiology Handbook Vol. 1 1992 ASM Press Washington, DC
19. Microbial susceptibility testing: MIC determinations were carried out at least in duplicate. Initial stock compounds were dissolved in DMSO at 1 mg/mL and subsequently diluted appropriately in DMSO. Test compounds were assayed at 3-25 μg/mL. DSA was assayed at 0.75-3.0 μg/mL. M. bovis BCG was maintained on M7H10 agar. A 0.5 MacFarland suspension was prepared using BACTEC diluent and 0.1 mL of culture was added to each BACTEC vial (4 mL) for testing. All bottles were incubated at 37°C and the growth index (GI) was monitored daily until the GI of the 1:100 control was ≥30. The MIC was defined as the lowest inhibitor concentration that yielded a ΔGI less than that of the 1:100 control bottle.
20. P.B. Jones, N.M. Parrish, T.A. Houston, A. Stapon, N.P. Bansal, J.D. Dick, and C.A. Townsend J. Med. Chem. 43 2000 3304
21. O. Zimhony, C. Vilcheze, and W.R. Jacobs J. Bacteriol. 186 2004 4051
22. S. Kikuchi, D.L. Rainwater, and P.E. Kolattukudy Arch. Biochem. Biophys. 295 1992 318